EyePoint Pharmaceuticals
EYPT
#5476
Rank
C$1.86 B
Marketcap
C$22.58
Share price
-4.98%
Change (1 day)
87.83%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -C$0.31 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$42.34 Million. In 2024 the company made an earning of -C$0.2 Billion a decrease over its 2023 earnings that were of -C$96.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.31 Billion52.23%
2024 -C$0.2 Billion104.29%
2023 -C$96.65 Million-29.88%
2022 -C$0.14 Billion87.2%
2021 -C$73.63 Million38.58%
2020 -C$53.13 Million-24.56%
2019 -C$70.43 Million
2017 -C$32.13 Million22.59%
2016 -C$26.21 Million-8.02%
2015 -C$28.49 Million-296.09%
2014 C$14.52 M-174.02%
2013 -C$19.63 Million37.42%
2012 -C$14.29 Million-56.29%
2011 -C$32.68 Million-1062.38%
2010 C$3.39 M-250.43%
2009 -C$2.26 Million-89.5%
2008 -C$21.5 Million
2005 -C$13.26 Million56.99%
2004 -C$8.45 Million73.7%
2003 -C$4.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
C$38.36 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-C$3.01 Million-98.99% Bahamas